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Abstract
Purpose Alcohol consumption is hypothesized to
increase the risk of endometrial cancer by increasing cir-
culating estrogen levels. This study sought to investigate
the association between lifetime alcohol consumption and
endometrial cancer risk.
Methods We recruited 514 incident endometrial cancer
cases and 962 frequency age-matched controls in this
population-based case–control study in Alberta, Canada,
from 2002 to 2006. Participants completed in-person
interviews querying lifetime alcohol consumption and
other relevant health and lifestyle factors. Participants
reported the usual number of drinks of beer, wine, and
liquor consumed; this information was compiled for each
drinking pattern reported over the lifetime to estimate
average lifetime exposure to alcohol.
Results Lifetime average alcohol consumption was rela-
tively low (median intake: 3.9 g/day for cases, 4.9 g/day for
controls). Compared with lifetime abstainers, women con-
suming [2.68 and B8.04 g/day alcohol and [8.04 g/day
alcohol on average over the lifetime showed 38 and 35 %
lower risks of endometrial cancer, respectively (p trend =
0.023). In addition, average lifetime consumption of all types
of alcohol was associated with decreased risks. There was no
evidence for effect modification by body mass index, phys-
ical activity, menopausal status, and hormone replacement
therapy use combined and effects did not differ by type of
endometrial cancer (type I or II).
Conclusion This study provides epidemiologic evidence
for an inverse association between relatively modest life-
time average alcohol consumption (approximately 1/4 to
1/2 drink/day) and endometrial cancer risk. The direction
of this relation is consistent with previous studies that
examined similar levels of alcohol intake.
Keywords Endometrial cancer  Alcohol drinking 
Ethanol  Beer  Wine  Liquor
Introduction
Endometrial cancer is hypothesized to develop in response
to high levels of estrogens unopposed by adequate levels of
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progesterone [1]. In epidemiologic studies, alcohol con-
sumption has been associated with increased levels of
circulating estrogens in pre- and post-menopausal women,
and may therefore increase the risk of endometrial cancer
[2–6]. Numerous epidemiological studies have investigated
the relation between overall alcohol consumption and
endometrial cancer risk; results are varied showing, for
some levels of consumption, statistically significant posi-
tive [7, 8] and inverse associations [9–16] or in most cases
no relation [17–36]. Only a few of those studies, however,
attempted to capture lifetime alcohol intake in their expo-
sure assessments [25, 26, 29, 36]. Given inconclusive
findings and the paucity of information regarding the
impact of alcohol intake over the lifetime on endometrial
cancer risk, we conducted this population-based case–
control study to assess specifically how alcohol consump-
tion over the entire lifetime influences endometrial cancer
risk and to investigate the role of different types and doses
of alcohol on risk.
Materials and methods
Study population
A population-based case–control study was conducted in
Alberta, Canada, from 2002 to 2006 to examine the asso-
ciation between physical activity and endometrial cancer
[37]. The Alberta Cancer Registry and pathology reports
were used to recruit incident, histologically confirmed,
primary endometrial cancer cases (n = 549). Random digit
dialing [38] was used to accrue population-based controls
(n = 1,036) who were frequency-matched to cases by age
(±5 years) in a 2:1 ratio. Response rates of 67.9 % for
cases and 52.2 % for controls were achieved. For the cases,
of the 808 who were eligible and received physician
approval, 249 women declined participation, seven could
not be contacted, and three were not endometrial cancer
cases upon re-review resulting in 549 eligible for this
analysis. For the controls, of the 1,988 eligible women
identified, 14 were excluded for no further contact and 948
refused participation leaving 1,036 who completed the
interview. Participants had no previous cancer history
(excluding non-melanoma skin cancer), and controls had
no history of hysterectomy or endometrial ablation.
Women were excluded if interviews were unsatisfactory
(n = 7 cases, n = 4 controls), or if they were missing
covariate data used in multivariable modeling (n = 28
cases, n = 70 controls). One participant’s beer consump-
tion was set to missing for one time period because of
unreasonably high reported consumption. The final analytic
sample comprised 514 cases and 962 controls. All partic-
ipants provided informed written consent, and ethical
approval for the study was obtained from the Alberta
Cancer Board and the University of Calgary Ethics Review
Boards.
Data collection
Information regarding demographic characteristics, endo-
metrial cancer risk factors, lifetime total physical activity
levels, smoking history, and hormone use was collected
through structured in-person interviews. Recall of previous
activity patterns and lifestyle behaviors was facilitated
through the use of cognitive interviewing methods [39, 40].
Anthropometric measures (height, weight, waist, and hip
circumferences) were taken in three repeat measurements
in a standardized fashion following the interview with
mean values of each measure used for analysis.
Regarding alcohol consumption, participants were asked
whether or not they had consumed six or more drinks of
beer, wine, or liquor in any given year of their life before
an assigned reference date (date of diagnosis for cases and
a comparable date for controls) in order to identify women
who have rarely consumed alcohol throughout their lives.
These women were classified as lifetime abstainers.
Women who answered yes to this question were asked the
usual number of drinks of beer (12 oz bottles or cans/
360 ml), wine (5 oz/140 ml), and liquor (1.5 oz/45 ml)
consumed per week or per month. This information was
collected for each pattern of drinking over each woman’s
lifetime with ages at the beginning and the ending of each
pattern recorded. Participants who reported a pattern that
started and ended in the same year were assigned 1 year of
consumption.
Statistical analysis
Unconditional logistic regression analyses were conducted
to estimate odds ratios (OR) and 95 % confidence intervals
(CI) for the risk of endometrial cancer in relation to the
levels of mean daily grams of alcohol intake from all
alcoholic beverages combined and for each alcohol type
(beer, wine, and liquor) individually. We converted the
volumes of reported alcohol intake into grams of alcohol
based on the conversion of 13.6 g of alcohol per standard
drink that was recorded [41]. Continuous alcohol con-
sumption in 1 g per day and 6.8 g per day increments
(equivalent to  a standard drink in Canada) for all types
of alcohol combined and each type individually was ana-
lyzed. In addition, mean daily grams of alcohol intake
averaged over the lifetime were analyzed categorically in
tertiles based on the distribution of drinking among the
controls. The likelihood ratio test was used to assess the
overall contribution of a categorical variable to the model.
To address the timing of alcohol exposure, women were
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categorized as a lifetime abstainer, former drinker (in our
study, these women quit drinking 2–58 years before ref-
erence date; median 17 years), or current drinker as of the
reference date. In addition, lifetime abstainers were com-
pared to ‘ever’ drinkers, defined as women reporting six or
more drinks in 1 year over a lifetime. Four additional
models estimated OR and 95 % CI for different life peri-
ods of alcohol consumption (B17, 18–34, 35–50, and C51
years of age); alcohol intake was analyzed both as a con-
tinuous variable and by tertiles within each age period. The
continuous alcohol intake measures were modeled using an
extra parameter to account for whether or not a participant
was ever exposed, thus taking into account the common
occurrence of unexposed participants in a continuous
measurement [42]. For all models, potential covariates
were identified a priori, and those that were deemed of
special interest (based on subject matter knowledge) were
assessed for both confounding and effect modification.
Covariates that were identified were as follows: age (years),
parity (nulliparous vs. multiparous), hormone replacement
therapy (HRT) and menopausal hormones (estrogen, estro-
gen ? progesterone, other, none versus post-menopausal sta-
tus, and no HRT), oral contraceptive use (ever vs. never),
residential status (rural vs. urban), type II diabetes, hypertension
(yes vs. no), comorbidities (none, 1, C2 among: thrombosis,
pulmonary embolism, myocardial infarction, stroke, and his-
tory of high cholesterol), mean lifetime MET-hours/week/year
of physical activity, weight (kg), height (cm), hip circumfer-
ence (cm), waist circumference (cm), glycemic load, fasting
plasma glucose (mg/dl), cholesterol (mg), total dietary folate
equivalent (mcg), insulin (mIU/l), and smoking status (current,
ex-smoker, occasional vs. nonsmoker).
The bootstrap method was used to select a reduced model
[43]. Covariates from the final models were assessed for
confounding with all the other covariates in the model using
the change in estimate method [44]. Our analyses by type of
alcohol (beer/wine/liquor) included models that were
adjusted for other types of alcohol intake. To assess linearity,
we fitted restricted cubic splines [45, 46] for variables that
were suspected to behave nonlinearly either based on pre-
vious evidence or on LOWESS plots of outcome versus each
variable. As a result, age at reference date was modeled
nonlinearly.
Effect modification was assessed for measured BMI
(kg/m2) at reference date, mean total lifetime physical
activity (MET-hours/week/year), and combined hormone
therapy (HRT) use and menopausal status (a variable that
combined levels for each type of HRT use (none, estrogen
only, estrogen and progesterone, other) with peri- or post-
menopausal status, vs. pre-menopausal and no HRT use) by
fitting an interaction term between mean daily alcohol
intake and each of these factors (one at a time) in the full
model, followed by a likelihood ratio test. We also
performed a polytomous logistic regression analysis to
determine if the risks associated with alcohol intake dif-
fered by endometrial cancer type (I vs. II). Regression
diagnostics and influence statistics were completed for final
regression models to assess adherence to regression
assumptions, and the Hosmer–Lemeshow goodness of fit
test to assess model fit [47]. All statistical analyses were
completed using Rstudio (Version 0.96.122, Boston, MA,
USA) and Stata version 12 (StataCorp, College Station,
TX, USA).
Results
As previously reported [37], our study population had a mean
age of 58 years, were primarily Caucasian (96 %), peri- or
post-menopausal (88.9 %), and nonusers of HRT (58.1 %).
On average, cases and controls were obese (median
BMI = 31.0) and overweight (BMI = 27.2), respectively.
Cases and controls were comparable on most characteristics,
except that cases, on average, were heavier and had a greater
median waist circumference. They were also more frequently
nulliparous, type II diabetics, and had a higher self-reported
prevalence of hypertension over their lifetime (Table 1).
Lifetime average alcohol consumption was relatively
modest in this study population with a median intake of
3.9 g/day (IQR 1.2, 9.8) and 4.9 g/day (IQR 1.9, 11.3) for
cases and controls, respectively (Table 1). Analyzed as a
continuous variable, alcohol consumption was not signifi-
cantly associated with endometrial cancer risk among the
drinkers in age- or multivariable-adjusted models (Table 2;
multivariable-adjusted OR = 0.97, 95 % CI 0.89, 1.03 for
every  drink increase in daily alcohol intake). However,
when assessed by tertiles, (Table 2), the highest level of
lifetime average alcohol consumption ([8.04 g/day) com-
pared to lifetime abstainers was inversely associated with
endometrial cancer risk (multivariable-adjusted OR = 0.65,
95 % CI 0.44–0.97, p trend = 0.023). Current and former
drinking status compared to lifetime abstainers was also
associated with decreased risks (multivariable-adjusted
OR = 0.70, 95 % CI 0.51–0.98 and OR = 0.68, 95 % CI
0.45, 1.04, respectively). Ever being a drinker was also
associated with a significant decreased risk (OR = 0.71,
95 % CI 0.52, 0.98). With the exception of former drinking,
age-adjusted and multivariable-adjusted risk estimates were
similar (Table 2). By the type of alcohol (Table 3), statis-
tically significant inverse associations were found for the
upper tertile of lifetime average wine consumption [3.29
g/day, above the middle tertile for average beer ([0.97
g/day) consumption, and for only the middle tertile of
average liquor consumption ([0.80 and B2.94 g/day)
compared to lifetime abstainers. Inverse trends were
observed for all alcohol types (p trend B 0.059). However,
Cancer Causes Control (2013) 24:1995–2003 1997
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across all levels of consumption jointly, only lifetime beer
consumption as a categorical variable was statistically sig-
nificantly associated with decreased risk of endometrial
cancer (p = 0.012 in the likelihood ratio test). While each
model adjusted for intakes of other types of alcohol, the odds
ratios and 95 % confidence intervals estimated without this
adjustment were very similar (data not shown).
There was no evidence for effect modification of these
risk estimates by BMI, lifetime physical activity, or HRT
use/menopausal status (data not shown). There was also no
difference in the association between alcohol intake and
each specific type of endometrial cancer (data not shown).
We also examined risk estimates by the age period in
which alcohol was consumed (B17, 18–34, 35–50, C51 years
Table 1 Distributions of
selected characteristics among
cases and controls, Alberta,
Canada, 2002–2006
(n = 1,476)
a Lifetime ethanol intake was
estimated as the mean of all
self-reported alcohol
consumption over an individual
drinking lifetime
b For those who reported
drinking alcohol, tertiles are
based on the distribution of the
controls
Risk factor Cases (n = 514) Controls (n = 962)
Median (25th, 75th
percentile) or n (%)
Median (25th, 75th
percentile) or n (%)
Age at reference date (year) 59 (53, 65) 59 (52, 66)
BMI (kg/m2) 31.0 (26.4, 36.8) 27.2 (24.1, 30.9)
Hip circumference (cm) 110.9 (102.6, 123.5) 104.8 (99, 112.5)
Waist circumference (cm) 95.5 (84, 108.6) 84.5 (76.5, 95.5)
Weight (kg) 81.1 (68.6, 98) 71.5 (63.1, 81.6)
Nulliparous 92 (17.9) 89 (9.3)
Menopausal status and hormone replacement therapy
use combined (HRT)
Peri- and post-menopausal, no HRT (referent category) 281 (54.7) 480 (49.9)
Peri- and post-menopausal, estrogen only 20 (3.9) 25 (2.6)
Peri- and post-menopausal, estrogen and progestin
combined
132 (25.7) 322 (33.5)
Peri- and post-menopausal other hormones 27 (5.3) 26 (2.7)
Pre-menopausal 54 (10.5) 109 (11.3)
Smoking status
Nonsmoker 263 (51.2) 487 (50.6)
Current smoker 68 (13.2) 116 (12.1)
Ex-smoker 162 (31.5) 339 (35.2)
Occasional smoker 21 (4.1) 20 (2.1)
MET-hours/week of lifetime total physical activity 100.4 (78.8, 126.5) 105.0 (82.8, 129.4)
Type II diabetes 62 (12.1) 51 (5.3)
Ever diagnosed with hypertension 161 (31.3) 171 (17.8)
Ever C6 alcoholic drinks per year over lifetime 407 (79.2) 819 (85.1)
Ever beer drinker 238 (46.3) 495 (51.5)
Ever wine drinker 337 (65.6) 695 (72.3)
Ever liquor drinker 358 (69.7) 699 (72.7)
Ethanol intake from any alcoholic
beverage over lifetime (g/day)a
3.9 (1.2, 9.8) 4.9 (1.9, 11.3)
Ethanol intake from beer over lifetime (g/day)a 1.3 (0.4, 4.9) 2.2 (0.6, 4.9)
Ethanol intake from wine over lifetime (g/day)a 0.9 (0.3, 3.5) 1.7 (0.4, 4.5)
Ethanol intake from liquor over lifetime(g/day)a 1.3 (0.5, 3.9) 1.6 (0.5, 3.9)
Tertiles of ethanol intake over lifetime (g/day)a,b
Lifetime abstainers 107 (20.8) 143 (14.9)
[0–B2.68 165 (32.1) 273 (28.4)
[2.68–B8.04 120 (23.4) 274 (28.5)
[8.04 122 (23.7) 272 (28.3)
Drink status
Lifetime abstainer 107 (20.8) 143 (14.9)
Former drinker 90 (17.5) 137 (14.2)
Current drinker 317 (61.7) 682 (70.9)
1998 Cancer Causes Control (2013) 24:1995–2003
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of age). In multivariable analysis, treating alcohol intake as a
continuous variable (1 g/day increments), alcohol intake was
not significantly associated with endometrial cancer risk
among drinkers for any of the age periods examined. Simi-
larly, in 6.8 g/day increments (*1/2 drink/day), alcohol
analyzed as a continuous variable was not statistically sig-
nificant in multivariable models, with adjusted ORs (95 %
CI) estimated as: 0.93 (0.74, 1.16), 0.96 (0.87, 1.07), 0.98
(0.89, 1.09), and 0.96 (0.86, 1.07) for the age periods B17,
18–34, 35–50, and 51? years. When alcohol consumption
was analyzed by tertiles within each age period, decreased
risks were observed across all age periods; ORs were sta-
tistically significant for only the middle (B17, 18–34,
35–50 years) or upper (18–34, 51? years) tertiles of
consumption.
Discussion
This large, population-based case–control study conducted
in Alberta, Canada, observed a statistically significant
30 % decreased risk of endometrial cancer for current
drinkers compared to lifetime abstainers, and a statistically
significant 29 % decreased risk for ever drinkers versus
lifetime abstainers. Our data showed that alcohol
consumption averaged over the lifetime in the range of
3–8 g per day (approximately 1/4 to 1/2 drinks per day in
Canada) was associated with a reduced risk of endometrial
cancer. A trend of decreasing risk of endometrial cancer
with increasing average lifetime intakes of alcohol was
similarly observed for beer, liquor, and wine consumption.
No evidence was found for effect modification by the other
factors examined.
To date, three meta-analyses of alcohol intake and endo-
metrial cancer risk have been described in the literature [30,
48, 49] generally showing no association or an increased risk
with relatively high levels of alcohol consumption. The vast
majority of studies included in these meta-analyses did not
examine lifetime alcohol intake. In the largest meta-analysis
that included data from 20 case–control and seven cohort
studies, Turati et al. [30] found no evidence of an association
when comparing drinkers to nondrinkers (RR = 0.95, 95 %
CI = 0.88–1.03) and only a slightly increased risk of
endometrial cancer for heavy drinkers (C14 drinks/week; C2
drinks/day) compared to nondrinkers that was not statisti-
cally significant (RR = 1.12, 95 % CI = 0.87–1.45). There
was some suggestion of a weak positive association among
very high alcohol drinkers particularly after menopause. In
our own study, the fact that very few women were heavy
drinkers within each menopausal group prohibits us from
Table 2 Multivariable-adjusted odds ratios estimates (OR) and associated 95 % confidence intervals (CI) for lifetime average daily alcohol
intake (n = 1,476)
Risk factor Cases (n) Controls (n) Age-adjusted Multivariable-adjusted
OR 95 % CI ORa 95 % CI
Mean daily alcohol intake
Per 1 g increase (continuous)b 1.00 0.99, 1.00 0.99 0.98, 1.00
Per 6.8 g increase (1/2 drink) (continuous)b 0.95 0.89, 1.01 0.97 0.89, 1.03
Ever drinker vs. lifetime abstainer 407 819 0.69 0.52, 0.92 0.71 0.52, 0.98
By tertilesc,d
Lifetime abstainers 107 143 1.00 Referent 1.00 Referent
[0–B2.68 g/day 165 273 0.81 0.59, 1.11 0.79 0.56, 1.13
[2.68–B8.04 g/day 120 274 0.58 0.42, 0.82 0.62 0.42, 0.91
[8.04 g/day 122 272 0.60 0.43, 0.84 0.65 0.44, 0.97
p trend 0.001 0.023
Type of drinkerd
Lifetime abstainer 107 143 1.00 Referent 1.00 Referent
Former drinkere 90 137 0.88 0.61, 1.27 0.68 0.45, 1.04
Current drinker 317 682 0.62 0.47, 0.83 0.70 0.51, 0.98
a Adjusted for age at reference, nulliparous (vs. multiparous), HRT and menopausal hormones, rural residential status (vs. urban), hypertension,
weight at reference, waist circumference, smoking status
b Among the alcohol drinkers
c For those who drink, tertiles are based on the distribution of the controls
d P values were estimated for the likelihood ratio test of the overall importance of a categorical variable. For alcohol intake by tertiles
p = 0.003, p = 0.046 for age- and multi-variable-adjusted models, respectively. For type of drinker, p = 0.002, p = 0.071 for age- and multi-
variable-adjusted models, respectively
e A former drinker is defined as any participant who consumed more than six drinks in any given year up to 1 year before reference date
Cancer Causes Control (2013) 24:1995–2003 1999
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reliably corroborating those results. In a second meta-anal-
ysis of seven prospective cohort studies conducted by Fri-
berg et al. [48], it was found that women who consumed[2.5
drinks/day compared with nondrinkers increased their risk
of endometrial cancer by 25 % (95 % CI = 0.98–1.58), but
again this increase was not statistically significant. Lastly,
Sun et al. [49] found no evidence for the association when
comparing ever-to-never alcohol consumption in six cohort
(RR = 1.04, 95 % CI = 0.91–1.18) and 14 case–control
studies (OR = 0.89, 95 % CI = 0.76–1.05), but did show a
statistically significant increased risk with liquor consump-
tion (RR = 1.22, 95 % CI = 1.03–1.45) based on an
analysis of seven studies that reported on the type of alcohol.
Our study did not support the latter analysis, showing instead
inverse associations with liquor consumption averaged over
the lifetime.
A key consideration when comparing our findings to
others in the literature may be the level of alcohol con-
sumed. Our study population reported a relatively low level
of alcohol consumption compared to many previous stud-
ies. In a dose–response meta-analysis by Turati et al. [30],
the risk of endometrial cancer was essentially unaltered by
alcohol intake until consumption reached approximately
30 g/day (slightly more than 2 drinks/day), at which point
the risk increased (pooled RR vs. nondrinkers = 1.39,
95 % CI, 0.89–2.19 for 38 g/day or approximately 3
drinks/day). In another dose–response meta-analysis by
Friberg et al. [48], however, it was shown that small doses
of alcohol, up to 1 drink/day (the range examined in our
study), may be weakly and nonsignificantly protective,
whereas higher doses of more than 2 drinks/day ([26 g/day
of alcohol) increased endometrial cancer risk nonsignifi-
cantly. The authors described this dose–response relation,
between 0 and[2.5 drinks/day, as a J-shaped curve, albeit
a shallow one. In our own data, we found no evidence that
mean daily alcohol intake behaved nonlinearly (p value for
nonlinear terms = 0.245), although the overall range of
alcohol consumption was relatively narrow. Further insight
into the effect of alcohol dose can be gained by comparison
with individual study results. When we limit a comparison
of our results only to previously reported risk estimates that
were based on similar levels of alcohol intake (comparing
risk estimates across categories of alcohol consumption
that included 0 to *13 g/day alcohol intake or B1 drink/
day), either there was no statistically significant association
[7, 8, 10, 17, 23–27, 29–33, 35, 36, 50] or there was a
statistically significant protective effect from alcohol, in
both cohort [9, 15] and case–control studies [11, 12, 14,
16]. Therefore, overall, earlier studies generally suggest
that low levels of alcohol intake (\1 drink/day) may have
no effect on endometrial cancer risk, or low intake may
have a protective effect, consistent with our results.
There are likely other reasons for inconsistent findings
across studies, including the method of exposure assess-
ment. While some studies have used very crude measures
of alcohol intake based on consumption patterns at a single
point in time, others have estimated alcohol consumption
patterns more comprehensively. To our knowledge, only
four previous studies have attempted to assess lifetime
alcohol consumption and endometrial cancer risk [25, 26,
29, 36]. Most recently, lifetime alcohol intake and endo-
metrial cancer risk were described in the context of the
EPIC study, a large prospective study of over 300,000
women who were followed on average for 11 years [36].
No association was found between endometrial cancer risk
Table 3 Multivariable-adjusted odds ratios estimates (OR) and
associated 95 % confidence intervals (CI) for lifetime average daily





ORb 95 % CI
Beerc
Complete abstainers 107 143 1.00 Referent
Beer lifetime abstainers 169 324 0.70 0.48, 1.02
[0–B0.97 g/day 105 166 0.94 0.63, 1.39
[0.97–B3.64 g/day 59 165 0.52 0.33, 0.82
[3.64 g/day 74 164 0.62 0.39, 0.98
p trendd 0.021
Winec
Complete abstainers 107 143 1.00 Referent
Wine lifetime abstainers 70 124 0.67 0.42, 1.06
[0–B0.78 g/day 144 232 0.79 0.53, 1.16
[0.78–B3.29 g/day 105 231 0.69 0.46, 1.03
[3.29 g/day 88 232 0.61 0.40, 0.93
p trendd 0.031
Liquorc
Complete abstainers 107 143 1.00 Referent
Liquor lifetime abstainers 49 120 0.70 0.43, 1.13
[0–B0.80 g/day 137 232 0.86 0.59, 1.25
[0.80–B2.94 g/day 109 233 0.59 0.40, 0.88
[2.94 g/day 112 234 0.66 0.43, 1.02
p trendd 0.059
a For those who drink alcohol, tertiles are based on the distribution of
the drinking controls in a given type of drink
b Adjusted for age at reference, nulliparous (vs. multiparous), HRT
and menopausal hormones, rural residential status (vs. urban),
hypertension, weight at reference, waist circumference, smoking
status, intake of other types of alcohol (beer/wine/liquor as a con-
tinuous variable)
c p values were estimated for the likelihood ratio test of the overall
importance of a categorical variable. For alcohol intake by tertiles,
p = 0.012, p = 0.16, p = 0.069 for beer, wine, and liquor models,
respectively
d p trend represents the significance of a test for trend across com-
plete abstainers and all tertiles of alcohol consumption that excludes
the drink-specific abstainers
2000 Cancer Causes Control (2013) 24:1995–2003
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and average lifetime consumption of alcohol, or with
alcohol intake at age 20; former drinkers versus average
lifetime intake of 0.1–6 g/day was associated with an
increased risk that was not statistically significant
(HR = 1.28, 95 % CI 0.98–1.68). No suggestion of dose–
response trends was observed across lifetime alcohol cate-
gories ranging from 0 to[36 g/day, and as in our study, no
evidence of effect modification was found. In a case–con-
trol study, Swanson et al. [29] found no evidence of an
association between alcohol consumption during adulthood
and endometrial cancer risk, although a statistically non-
significant protective effect of [4 drinks/week or approxi-
mately  drink/day (adjusted RR vs. no alcohol = 0.34,
95 % CI 0.10–1.16) was observed for women under
55 years of age. Newcomb et al. [26] examined endometrial
cancer risk in relation to participants’ alcohol intake 5 years
before the interview and also in their 20 s but found no
statistically significant association in either time period;
however, a significant inverse association was observed in a
small group of pre-menopausal women who, 5 years before
the interview, consumed 1 drink/day or more. In an article
by McCann et al. [25], it was unclear which life period was
represented for estimated alcohol intake.
In our own study, we did not demonstrate that the time
of life in which alcohol was consumed was important with
respect to endometrial cancer risk. Through our age period-
specific multivariable models, we observed similar risk
estimates across four age periods since most women in our
study, who generally consumed low amounts of alcohol,
likely maintained a fairly consistent alcohol intake over
their lifetimes (within most individuals, we observed only
minor increases in consumption over these four age peri-
ods; data not shown). Our finding that ‘ever,’ ‘current,’ and
‘former’ (potentially early life) drinkers in our study
experienced lower risks of endometrial cancer relative to
lifetime abstainers supports a hypothesis that light alcohol
consumption at any time in life may be beneficial. Our age
period-specific analyses provide valuable insight that is
lacking in our analysis of average lifetime alcohol intake, a
variable that does not account for changing consumption
patterns over time. However, it is also important to note
that none of our age-specific analyses controlled for the
effect of changing exposure over time.
Further considerations when comparing our findings to
previous studies include adjustment for confounders and
the source of study cases and controls. Important con-
founders to consider in the relation of alcohol and endo-
metrial cancer include oral contraceptive use, menopausal
status, physical activity, smoking, and fruit or vegetable
intake. Failure to adjust for these may have lead to inac-
curate effect estimates in some studies. Furthermore,
among case–control studies, study designs have included
both hospital-based and population-based studies like ours.
The population-based design minimizes the possibility for
selection bias and may therefore produce more accurate
results. When stratifying case–control studies in their meta-
analysis, Turati et al. [30] found that data from population-
based studies showed a statistically significant decreased
risk of endometrial cancer for drinkers compared to low/
nondrinkers, while data from hospital-based studies was
inconclusive.
It is biologically plausible that alcohol consumption is
associated with endometrial cancer risk. While epidemi-
ologic studies have demonstrated unfavorable changes in
sex hormone levels with alcohol intake [2–6], and estro-
gens may be related to increased endometrial cancer risk
through inducing mitotic activity, DNA replications, and
mutations [51], this mechanism does not support our
findings of reduced endometrial cancer risk among lifetime
drinkers. Another possible mechanism that would support
our findings involves the insulin response: alcohol con-
sumption has been associated with improved insulin sen-
sitivity and decreased fasting insulin levels [52], both of
which have been associated with endometrial cancer risk,
including in our study population [53]. Furthermore,
alcohol may increase adiponectin levels [54] that are
inversely related to insulin resistance. To further support
this hypothesis, the growth of endometrial cells in vitro is
stimulated through insulin, which binds to insulin receptors
in the endometrium [55]. These opposing mechanisms,
whereby alcohol may act as an effect modifier in the
hypothesized causal association between insulin exposure
and endometrial cancer risk, may help to explain some
contradictory findings in the literature to date.
Certain limitations of our study and statistical analyses
must be considered when interpreting our findings. The
retrospective case–control design of our study can be prone
to measurement error due to the difficulty in recalling past
behavior, particularly over the lifetime. To minimize this
error in our study, all interviewers were trained in cognitive
interviewing methods and used lifetime calendars as recall
aids to help respondents recall their lifetime alcohol con-
sumption. Social desirability bias is also possible in our
data given that alcohol intake was the exposure of interest,
i.e., some women may have underreported their intake. In
addition, a healthy volunteer bias may have occurred given
the lower response rate among the controls and their
slightly higher educational levels and overall health.
Although, in comparison with a general population sample
of Canadians that we made for this study population [37],
we concluded that no major selection bias was evident for
our control population. Finally, our capacity for subgroup
analyses of our data was limited by relatively small num-
bers of cases and controls in some categories of women;
therefore, we may have not had sufficient power to detect
some statistically significant associations.
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In conclusion, this population-based study provides
evidence for a protective association between alcohol
consumption over the lifetime and endometrial cancer risk.
Our data were suggestive that \1 drink of alcohol per day
averaged over the lifetime is associated with a reduced risk
of endometrial cancer, which is consistent with a number
of previous studies examining similar levels of alcohol
intake. These findings do not warrant advising increased
alcohol consumption to reduce the risk of endometrial
cancer as alcohol consumption may increase risk of several
other important diseases including other cancers.
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